Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Spleen tyrosine kinase (SYK) and Zeta-chain associated protein kinase 70 (ZAP70) share homology and functions but have distinct expression patterns in B and T cells.
• This segregation is conserved across evolution and is vital for immune cell development and function.

Purpose of the Study:

• To investigate the role of ZAP70 expression in B cell malignancies.
• To understand the mechanistic basis by which ZAP70 contributes to B cell survival and transformation.
• To explore the implications of ZAP70 dysregulation in autoimmune diseases and B cell cancers.

Main Methods:

• Analysis of ZAP70 expression in various B cell malignancies.
• Utilizing genetic mouse models (B-ALL, B-CLL) with conditional Zap70 expression or deletion.
• Investigating the impact of inducible Zap70 activation on B cell development and negative selection.

Main Results:

• Aberrant ZAP70 expression is a common hallmark in a wide spectrum of B cell malignancies.
• ZAP70 competes with SYK in B cells, shifting signaling from negative selection to pro-survival pathways.
• Conditional Zap70 expression accelerated B-ALL and B-CLL onset in mice, while deletion impaired malignant transformation.
• Inducible ZAP70 activation disrupted negative selection of autoreactive B cells, leading to autoantibody production.

Conclusions:

• Strict segregation of SYK and ZAP70 kinases is essential for proper B cell selection.
• Aberrant ZAP70 expression in B cells promotes survival and malignant transformation.
• Maintaining kinase segregation acts as a critical safeguard against B cell malignancies and autoimmune disorders.